Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Compare within a sector
MetricCVSCVS HealthCICignaDGXQuest Diagnostics
Snapshot
Price$97.97$282.29$241.65
Market cap$133.62B$76.12B$23.88B
Valuation
P/E42.3x11.9x26x
Forward P/E60.5x9.1x22.7x
Growth
Revenue growth7.6%8.8%11.0%
EPS growth-46.0%30.5%14.9%
Profitability
Net margin0.7%2.3%9.1%
ROE3.9%15.2%14.1%
Balance sheet & cash
Debt / equity0.86x0.75x0.82x
Free cash flow yield9.9%9.7%5.4%
Dividend yield2.6%2.1%1.7%
Verdict
Investment ratingWeak· 32Favorable· 60Neutral· 52

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearCVStoday $98CItoday $282DGXtoday $242
2027$74.95 – $109.92+12% CAGR$276.23 – $405.13+44% CAGR$208.21 – $305.37+26% CAGR
2028$76.45 – $112.12+7% CAGR$360.39 – $528.58+37% CAGR$239.19 – $350.81+20% CAGR
2029$77.97 – $114.36+5% CAGR$470.21 – $689.64+35% CAGR$274.78 – $403.01+19% CAGR
2030$79.53 – $116.65+4% CAGR$613.48 – $899.77+34% CAGR$315.66 – $462.97+18% CAGR
2031$81.13 – $118.98+4% CAGR$800.41 – $1,173.93+33% CAGR$362.64 – $531.87+17% CAGR
5-yr CAGR-3.7% – 4.0%23.2% – 33.0%8.5% – 17.1%